There have been some newspaper articles and some letters to the editor recently about the cost of prescription drugs. I do not know all the causes of expensive prescription drugs, but I suspect that it is a very complicated issue that requires more work to resolve.

New Hampshire House Bill 656 “establish(es) a committee to study the impact of financial initiatives for commercially insured members by drug manufacturers on prescription drug prices and health insurance premiums.” At one of the early hearings of HB 656, a group offered info from USC Schaeffer.

The info at this site describes 7 entities involved in the flow of money in prescription drugs. Their chart shows the manufacturers at the top and contributing the most to the cost. Down the right side of the chart are two distributors, wholesalers and pharmacies, then the prescription drug user. Down the left side of the chart are three administration and service providers: pharmacy benefit managers, health plan insurers and health plan sponsors. The USC info includes a second chart that shows the flows of drugs, money and services. That second chart also shows “rebates” and “coupons,” both of which might actually contribute to the high cost of prescription drugs.

The cost of prescription drugs looks complicated and convoluted. I hope the New Hampshire Committee established by HB 656 looks at all of the info available and develops a report that reduces the confusion and identifies action items to reduce the cost of prescription drugs.

RICHARD MOORE

Chichester